Quintet Private Bank Europe S.A. Has $6.68 Million Holdings in CME Group Inc. (NASDAQ:CME)

Quintet Private Bank Europe S.A. increased its stake in shares of CME Group Inc. (NASDAQ:CME) by 29.0% in the third quarter, Holdings Channel reports. The firm owned 30,287 shares of the financial services provider’s stock after buying an additional 6,815 shares during the quarter. Quintet Private Bank Europe S.A.’s holdings in CME Group were worth $6,683,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the stock. Harbor Capital Advisors Inc. grew its stake in shares of CME Group by 0.6% during the third quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock worth $1,723,000 after purchasing an additional 45 shares during the period. CVA Family Office LLC grew its stake in CME Group by 11.8% in the third quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock valued at $96,000 after acquiring an additional 46 shares during the period. Lester Murray Antman dba SimplyRich grew its stake in CME Group by 0.7% in the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock valued at $1,507,000 after acquiring an additional 50 shares during the period. Essex LLC grew its stake in CME Group by 3.3% in the first quarter. Essex LLC now owns 1,649 shares of the financial services provider’s stock valued at $355,000 after acquiring an additional 52 shares during the period. Finally, Quent Capital LLC grew its stake in CME Group by 10.2% in the third quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock valued at $131,000 after acquiring an additional 55 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Stock Performance

NASDAQ:CME traded down $0.77 on Monday, hitting $222.84. The company’s stock had a trading volume of 184,845 shares, compared to its average volume of 1,909,385. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. The stock has a fifty day moving average of $220.69 and a two-hundred day moving average of $209.49. The firm has a market capitalization of $80.24 billion, a P/E ratio of 23.51, a price-to-earnings-growth ratio of 5.67 and a beta of 0.55. CME Group Inc. has a one year low of $190.70 and a one year high of $230.36.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The company had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the prior year, the business earned $2.25 earnings per share. The firm’s revenue for the quarter was up 18.4% on a year-over-year basis. Research analysts predict that CME Group Inc. will post 10.23 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were given a $1.15 dividend. This represents a $4.60 annualized dividend and a dividend yield of 2.06%. The ex-dividend date was Monday, September 9th. CME Group’s payout ratio is 48.37%.

Insider Activity

In other news, insider Timothy Francis Mccourt sold 1,374 shares of the company’s stock in a transaction that occurred on Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the transaction, the insider now owns 7,275 shares of the company’s stock, valued at approximately $1,652,298. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Timothy Francis Mccourt sold 1,374 shares of the stock in a transaction that occurred on Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the sale, the insider now directly owns 7,275 shares in the company, valued at $1,652,298. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 15,221 shares of company stock valued at $3,351,895. 0.30% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on CME shares. Oppenheimer boosted their target price on CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research note on Thursday, October 24th. Barclays boosted their target price on CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a research note on Thursday, October 24th. Keefe, Bruyette & Woods boosted their price target on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Citigroup boosted their price target on CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a report on Thursday, October 24th. Finally, JPMorgan Chase & Co. boosted their price target on CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, CME Group has an average rating of “Hold” and a consensus target price of $222.73.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.